Nyxoah (NYXH) Cash & Equivalents Growth (1y) (2021 - 2026)
Nyxoah (NYXH) Cash & Equivalents Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -19.91% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -3.67% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -3.76% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 21.48% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -14.50% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -18.09% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 19.45% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 27.52% |
| 10 | Nyxoah | 90.94 Mn | 90.94 Mn | 5.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 189.66% |
| Dec 31, 2025 | -4.44% |
| Sep 30, 2025 | 40,244.71% |
| Jun 30, 2025 | -13.82% |
| Mar 31, 2025 | -1.78% |
| Dec 31, 2024 | 57.18% |
| Sep 30, 2024 | 118.35% |
| Jun 30, 2024 | 65.13% |
| Mar 31, 2024 | -33.62% |
| Dec 31, 2023 | 27.40% |
| Sep 30, 2023 | -84.08% |
| Jun 30, 2023 | -77.59% |
| Mar 31, 2023 | -61.11% |
| Dec 31, 2022 | -88.23% |
| Sep 30, 2022 | -45.47% |
| Dec 31, 2021 | 40.86% |